JLK , a medical artificial intelligence (AI) specialist, has expanded its supply chain in the domestic hospital market and is actively pursuing sales growth by providing a subscription-based AI solution for stroke diagnosis and treatment to Chung-Ang University Hospital.
JLK is providing AI solutions to Chung-Ang University Hospital, including JLK-CTP, a brain imaging analysis software, to support acute stroke diagnosis and treatment decision-making. The solution reportedly provides automatic analysis results within minutes of brain imaging, systematically supporting time-sensitive clinical decision-making.
Professor Chan-Young Park of the Department of Neurology at Chung-Ang University Hospital said, “Based on the results of AI analysis, we can quickly organize treatment priorities and the efficiency of communication between medical staff is also greatly improved,” and “As field utilization increases, the speed and accuracy of the overall stroke treatment flow are also improving.”
Chung-Ang University Hospital is a leading general hospital in the metropolitan area. It boasts a robust emergency medical system and stroke treatment infrastructure, and operates a multidisciplinary collaborative care system and standardized treatment protocols. This allows it to provide integrated treatment capabilities, from acute care to rehabilitation, research, and education.
JLK is expanding its subscription-based AI solution offerings, focusing on domestic university hospitals and general hospitals, including Chung-Ang University Hospital. Based on a portfolio encompassing the entire stroke diagnostic spectrum, including NCCT, CTA, CTP, and MRI, rather than a single product, JLK is pursuing hospital-tailored subscription contracts and establishing a stable recurring revenue structure.
Kim Dong-min, CEO of JLK, said, “Use cases at major university hospitals are becoming an important reference for domestic market expansion and sales growth,” and added, “We plan to strengthen our domestic sales base by expanding subscription-based supply centered on clinically proven AI solutions.”
- See more related articles
You must be logged in to post a comment.